Market Cap 103.91M
Revenue (ttm) 0.00
Net Income (ttm) -98.33M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 624,800
Avg Vol 567,968
Day's Range N/A - N/A
Shares Out 33.20M
Stochastic %K 31%
Beta 1.49
Analysts Strong Sell
Price Target $21.57

Latest News on LXEO

Nasdaq Surges Over 1%; Lexeo Therapeutics Shares Plummet

Jul 15, 2024, 12:05 PM EDT - 9 months ago

Nasdaq Surges Over 1%; Lexeo Therapeutics Shares Plummet


Lexeo Therapeutics Proposes Terms For $126 Million IPO

Oct 31, 2023, 1:49 PM EDT - 1 year ago

Lexeo Therapeutics Proposes Terms For $126 Million IPO


Lexeo Therapeutics Starts $100 Million U.S. IPO Effort

Oct 2, 2023, 1:49 PM EDT - 1 year ago

Lexeo Therapeutics Starts $100 Million U.S. IPO Effort